Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Principal U.S. Small Cap Index ETF | PSC | Dec 20, 2024 | 51.64 | +0.82 |
Priority Income Fund | PRIF-K | Dec 20, 2024 | 20.68 | -3.00 |
Priority Income Fund | PRIF-L | Dec 20, 2024 | 23.22 | -0.77 |
Priority Income Fund D Pref | PRIF-D | Dec 20, 2024 | 24.14 | 0.00 |
Priority Income Fund F Pref | PRIF-F | Dec 20, 2024 | 24.50 | -0.61 |
Priority Income Fund G Pref | PRIF-G | Dec 20, 2024 | 25.34 | +0.04 |
Priority Income Fund I Pref | PRIF-I | Dec 20, 2024 | 23.36 | -0.09 |
Priority Income Fund J Pref | PRIF-J | Dec 20, 2024 | 23.14 | +0.35 |
Priority Income Fund Pref | PRIF-H | Dec 20, 2024 | 24.52 | 0.00 |
Priority Technology | PRTH | Dec 20, 2024 | 8.59 | -0.58 |
Privia Health Group | PRVA | Dec 20, 2024 | 20.07 | -0.30 |
Pro-Dex | PDEX | Dec 20, 2024 | 48.74 | +5.16 |
ProAssurance | PRA | Dec 20, 2024 | 15.76 | -0.44 |
Procaps Group | PROC | Dec 20, 2024 | 2.51 | +2.87 |
Procept BioRobotics | PRCT | Dec 20, 2024 | 81.17 | +0.48 |
Processa Pharmaceuticals | PCSA | Dec 20, 2024 | 0.85 | -9.84 |
Procore Technologies | PCOR | Dec 20, 2024 | 76.53 | +1.39 |
Procter & Gamble | PG | Dec 20, 2024 | 168.06 | -0.67 |
Professional Diversity Network | IPDN | Dec 20, 2024 | 0.44 | -9.36 |
Proficient Auto Logistics | PAL | Dec 20, 2024 | 7.65 | -0.39 |
Profire Energy | PFIE | Dec 20, 2024 | 2.54 | 0.00 |
Profound Medical | PROF | Dec 20, 2024 | 7.25 | -0.41 |
ProFrac A | ACDC | Dec 20, 2024 | 6.99 | -2.10 |
PROG | PRG | Dec 20, 2024 | 42.12 | +1.03 |
Progress Software | PRGS | Dec 20, 2024 | 66.38 | +0.70 |
Progressive | PGR | Dec 20, 2024 | 239.97 | +0.11 |
Progyny | PGNY | Dec 20, 2024 | 14.34 | +1.06 |
ProKidney | PROK | Dec 20, 2024 | 1.51 | +3.42 |
Prologis | PLD | Dec 20, 2024 | 103.32 | +1.89 |
ProMIS Neurosciences | PMN | Dec 20, 2024 | 0.92 | +1.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.